344 related articles for article (PubMed ID: 33351863)
41. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
42. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.
Kumar N; Admane N; Kumari A; Sood D; Grover S; Prajapati VK; Chandra R; Grover A
Sci Rep; 2021 Apr; 11(1):7653. PubMed ID: 33828130
[TBL] [Abstract][Full Text] [Related]
44. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
45. Design of multi-epitope chimeric vaccine against Monkeypox virus and SARS-CoV-2: A vaccinomics perspective.
Al-Madhagi H; Kanawati A; Tahan Z
J Cell Mol Med; 2024 May; 28(10):e18452. PubMed ID: 38801408
[TBL] [Abstract][Full Text] [Related]
46. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
[TBL] [Abstract][Full Text] [Related]
47. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
Srivastava S; Verma S; Kamthania M; Kaur R; Badyal RK; Saxena AK; Shin HJ; Kolbe M; Pandey KC
JMIR Bioinform Biotech; 2020; 1(1):e19371. PubMed ID: 32776022
[TBL] [Abstract][Full Text] [Related]
48. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
49. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
[TBL] [Abstract][Full Text] [Related]
50. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.
Abbasi BA; Saraf D; Sharma T; Sinha R; Singh S; Sood S; Gupta P; Gupta A; Mishra K; Kumari P; Rawal K
PeerJ; 2022; 10():e13380. PubMed ID: 35611169
[TBL] [Abstract][Full Text] [Related]
51. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Singh J; Malik D; Raina A
Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
[TBL] [Abstract][Full Text] [Related]
52. Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
Das BK; Chakraborty D
J Phys Chem Lett; 2020 Nov; 11(22):9920-9930. PubMed ID: 33174418
[TBL] [Abstract][Full Text] [Related]
53. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.
Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM
Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130
[TBL] [Abstract][Full Text] [Related]
54. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
Shehata MM; Mahmoud SH; Tarek M; Al-Karmalawy AA; Mahmoud A; Mostafa A; M Elhefnawi M; Ali MA
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684763
[TBL] [Abstract][Full Text] [Related]
55. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
Saba AA; Adiba M; Saha P; Hosen MI; Chakraborty S; Nabi AHMN
Comput Biol Med; 2021 Sep; 136():104703. PubMed ID: 34352457
[TBL] [Abstract][Full Text] [Related]
56. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D
Front Immunol; 2021; 12():732693. PubMed ID: 34899692
[TBL] [Abstract][Full Text] [Related]
57. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
58. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.
Mishra SK; Priya P; Rai GP; Haque R; Shanker A
Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941
[TBL] [Abstract][Full Text] [Related]
59.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
60. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.
Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R
Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]